In a rare enforcement action of what may be a new indication of focus by the SEC, the Commission entered a settlement with a large broker-dealer in recently for Rule 13h-1 violations for large trader reporting failures. Although this enforcement action targeted a broker-dealer issue, it’s worth noting for public companies because individual executives sometimes
DOJ Brings First Criminal Charges Stemming From Use of Rule 10b5-1 Plan
Last week, the DOJ unsealed an indictment against the CEO of a publicly traded healthcare company (the Executive) relating to charges of an insider trading scheme. The indictment represents the first time the DOJ has brought criminal insider trading charges stemming from an executive’s use of a Rule 10b5-1 trading plan. The investigation is part